Concurrent onabotulinumtoxina treatment of cervical dystonia and concomitant migraine
Headache: The Journal of Head and Face Pain,  Clinical Article

Winner PK et al. – Concurrent treatment with onabotulinumtoxinA is effective and well tolerated in controlling the symptoms of cervical dystonia complicated by concurrent migraine.

Methods
  • An open–label pilot study was conducted for 7.5 months in patients at least 18 years old with primary cervical dystonia of moderate severity (baseline rating of at least 20 on the Toronto Western Spasmodic Torticollis Rating Scale) complicated by migraine headache meeting the International Classification of Headache Disorders–II criteria for migraines with or without aura.
  • Each patient received 2 cycles of treatment at Visit 3 (baseline) and Visit 6 (Day 90).
  • For cervical dystonia, each patient was injected with a maximum of 175 units.
  • At the same visit, a maximum of 125 units was also injected for migraine using a fixed–site, fixed–dose injection paradigm, with additional cervical dystonia injection–site treatment to a maximum dose of 300 units.
  • Patients were assessed following onabotulinumtoxinA injection and at follow–up on Visit 4 (Day 30), Visit 5 (Day 60), Visit 6 (Day 90), and at Visits 7, 8, and 9 (Days 120, 150, and 180).
  • The primary outcome measures for this study were change in Toronto Western Spasmodic Torticollis Rating Scale total score for cervical dystonia and frequency of headache episodes per 28–day period.
  • Migraine episodes were defined as at least 4 hours of sustained pain with no upper limit.
  • An episode was considered new if the patient was pain free for at least 24 hours.
  • Secondary study end points included number of headache days per month, headache intensity, headache disability (assessed using Headache Impact Test–6 and the Migraine Disability Assessment score scales), acute headache medication use, resource utilization, and allodynia pain.
  • Adverse events were reported.

Results
  • A total of 25 patients (24 women, mean age 50.5 years; mean age of disease onset 21.9 years) were enrolled in the study.
  • Patients experienced improvement in cervical dystonia symptoms with significant reductions from baseline in Toronto Western Spasmodic Torticollis Rating Scale scores at 30, 60, 90, 120, 150, and 180 days (–9.84 ± 8.49, –12.67 ± 8.22, –13.63 ± 7.27, –14.92 ± 7.05, –4.76 ± 6.97, –14.49 ± 6.14, respectively, P < .0001 at all time points from a baseline of 31.03 ± 3.61).
  • Changes from baseline were assessed using the t–test.
  • Reductions in the number of headache episodes from baseline on concurrent onabotulinumtoxinA treatment for coexistent chronic migraine did not attain significance.
  • However, patients experienced significant reductions from baseline in the number of headache days at 90, 120, and 180 days (–3.39 ± 6.78, P = .0289; –4.29 ± 7.94, P = .0194; –4.38 ± 7.99, P = .0178, respectively, from a baseline of 15.33 ± 6.76).
  • Changes from baseline were assessed using the t–test.
  • The change from baseline in Headache Impact Test–6 total scores was significant at 30, 60, 90, 150, and 180 days (3.21 ± 4.14, P = .0009; –3.04 ± 4.04, P = .0012; –2.41 ± 2.79, P = .0006; –2.59 ± 3.87, P = .0050; –3.09 ± 3.80, respectively, from a baseline of 22.68 ± 3.20).
  • Changes from baseline were assessed using the t–test.
  • The change from baseline in Migraine Disability Assessment was significant at 120, 150, and 180 days (–38.09 ± 47.87, P < .0001, Wilcoxon signed rank test; –16.91 ± 62.69, P = .0358, Wilcoxon signed rank test; ?23.73 ± 40.57, P = .0122, t–test, respectively, from a baseline of 56.68 ± 50.41).
  • There were no serious adverse events or treatment–related disc

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Neurology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Neurology Articles

1 Consumption of nuts and legumes and risk of stroke: a meta-analysis of prospective cohort studies Nutrition, Metabolism & Cardiovascular Diseases, July 28, 2014    Evidence Based Medicine    Clinical Article

2 Patent foramen ovale closure versus medical therapy for stroke prevention: meta analysis of randomized trials and review of heterogeneity in meta analyses Canadian Journal of Cardiology, August 7, 2014    Evidence Based Medicine    Review Article    Clinical Article

3 Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin Stroke, August 14, 2014    Clinical Article

4 Supplementation of folic acid and vitamin B12 reduces plasma levels of asymmetric dimethylarginine in patients with acute ischemic stroke Journal of Clinical Neuroscience, August 18, 2014    Clinical Article

5 Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials The Lancet, August 11, 2014    Evidence Based Medicine    Clinical Article

6 Modification of outcomes with aspirin or apixaban in relation to female and male sex in patients with atrial fibrillation Stroke, July 11, 2014    Clinical Article

7 Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab JAMA Neurology, July 18, 2014    Clinical Article

8 Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques Stroke, May 2, 2014    Clinical Article

9 New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach Neuro-Oncology, August 4, 2014    Clinical Article

10 Risk predictors of stroke and mortality following ablation for atrial fibrillation: The California experience 2005-2009 Heart Rhythm, August 1, 2014    Clinical Article

11 Zolpidem and the risk of Parkinson's disease: A nationwide population-based study Journal of Psychiatric Research, August 1, 2014    Clinical Article

12 Antiepileptics in migraine prophylaxis: An updated Cochrane review Cephalalgia, August 14, 2014    Clinical Article

13 Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: A double-blind randomized clinical trial Human Psychopharmacology: Clinical and Experimental, July 15, 2014    Clinical Article

14 Medication-overuse headache: a review Full Text Journal of Pain Research, July 2, 2014    Free full text    Review Article

15 Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): A multicentre, randomised, open-label, phase 3 trial The Lancet Oncology, August 26, 2014    Clinical Article

16 Role of traditional nonsteroidal anti-inflammatory drugs in Alzheimer's disease: A meta-analysis of randomized clinical trials American Journal of Alzheimer's Disease and Other Dementias, July 16, 2014    Clinical Article

17 Reirradiation of recurrent medulloblastoma Cancer, August 1, 2014    Clinical Article

18 Temozolomide after radiotherapy in recurrent low grade diffuse brainstem glioma in adults Journal of Neuro-Oncology, August 21, 2014    Clinical Article

19 Lacunar strokes in patients with diabetes mellitus: risk factors, infarct location, and prognosis Stroke, August 26, 2014    Clinical Article

20 Low testosterone and the risk of dementia in elderly men Alzheimer's & Dementia, July 30, 2014    Clinical Article

Indexed Journals in Neurology: Current Opinion in Neurology, Stroke, Seizure, Cephalgia, Brain Injurymore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close